Efalizumab in the treatment of psoriasis

Article Properties
  • Language
    English
  • DOI (url)
    10.1586/14750708.1.2.197
  • Publication Date
    2004/11/01
  • Journal
    Therapy
  • Indian UGC (journal)
  • Refrences
    19
  • Christine Della Croce
  • Vicky Kwan Wong
  • Mark G Lebwohl
Cite
Della Croce, Christine, et al. “Efalizumab in the Treatment of Psoriasis”. Therapy, vol. 1, no. 2, 2004, pp. 197-02, https://doi.org/10.1586/14750708.1.2.197.
Della Croce, C., Kwan Wong, V., & Lebwohl, M. G. (2004). Efalizumab in the treatment of psoriasis. Therapy, 1(2), 197-202. https://doi.org/10.1586/14750708.1.2.197
Della Croce C, Kwan Wong V, Lebwohl MG. Efalizumab in the treatment of psoriasis. Therapy. 2004;1(2):197-202.
Refrences
Title Journal Journal Categories Citations Publication Date
Immunomodulatory drugs for psoriasis BMJ 23 2003
Immunomodulatory drugs for psoriasis 2004
Immunomodulatory drugs for psoriasis 1998
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab Expert Opinion on Biological Therapy
  • Technology: Chemical technology: Biotechnology
  • Medicine: Medicine (General)
  • Medicine: Medicine (General): Medical technology
  • Medicine: Medicine (General)
 4 2003
10.1016/S0190-9622(03)01144-7